Sparteine CAS: 492-08-0/90-39-1

Detailed Description Sparteine CAS: 492-08-0/90-39-1

BAISFU Sparteine is a class 1a antiarrhythmic agent; a sodium channel blocker. That is the predominant alkaloid in Lupinus mutabilis, and is thought to chelate the bivalent cations calcium and magnesium. It is not FDA approved for human use as an antiarrhythmic agent, and it is not included in the Vaughn Williams classification of antiarrhythmic drugs.
It is also use as a chiral ligand in organic chemistry, especially in syntheses involving organolithium reagents.

Applications

1.  As raw material of health products for smoking cessation medicine and cough medicine, it is widely use in health industry.
2.  As emergency medicine for treating respiratory failure, it is widely use in pharmaceutical field.

Pharmaceutical intermediates and drug synthesis: This is the most valuable application area of Sparteine. It is widely use as a catalyst or reagent for synthesizing key chiral intermediates of various drugs (especially cardiovascular drugs and neuroactive drugs). Its role in constructing complex chiral molecular frameworks is irreplaceable.
Organic synthesis chemistry: In basic research and fine chemical industries, Sparteine is an important catalyst and ligand.

Functions

1. Reducing and eliminating the smokers dependence on nicotine to achieve the purpose of smoking cessation.
2. A respiratory stimulant and booster effects on the cerebral circulation.
3. The function of pharmacological, such as anti-microbial, anti- infection, elevated white blood cell.
4. Has strong anti-cancer activity.
5. Significant regulating activity on plant growth.
6. With the function of expectorant and antitussive.